PREDICTING AND MANAGING CHEMOTOXICITY
TheraGuide® 5-FU — A Test that Predicts 5-FU Toxicity
If you are considering 5-FU-related chemotherapy for a specific patient, the comprehensive TheraGuide® 5-FU test can help you evaluate his/her risk for serious side effects.
TheraGuide® 5-FU detects variations in 2 genes: DYPD and TYMS, which are associated with a significantly increased risk for dose-limiting toxicities. The test requires only a small sample of the patient’s blood, which is sent to Myriad Genetic Laboratories for analysis. Instructions and materials needed for sample collection can be ordered here: Sample Collection Kit
Comprehensive results are typically delivered to you in just 7 days.
This quick turnaround allows you to confirm if the patient is at risk for serious
5-FU toxicities before starting chemotherapy, helping you customize medical management, enhance patient monitoring, limit the incidence and severity of side effects, and improve quality of life.
For more information about TheraGuide® 5-FU, please contact us at
1-800-469-7423 or theraguide@myriad.com.
